ObjectivesThe aim was to evaluate the impact of diabetes on the outcome of periodontal treatment based on massive data analyses.Materials and methodsData originated from the database of a major German National Health Insurance. Patients who underwent periodontal treatment were allocated to four groups according to their medical condition: type 1 diabetes (D1), type 2 diabetes with the intake of oral anti-diabetics (D2M), type 2 diabetes without the intake of oral anti-diabetics (D2), and a control group without diabetes (ND). Four-year Kaplan-Meier survival analyses on the patient level and multivariate regression analyses were conducted for tooth extraction.ResultsOf 415,718 patients, 4139 matched the criteria for D1, 22,430 for D2M, and 23,576 for D2. At 4 years, the cumulative survival rate (no extraction) was 51.7% in the D1 group, 54.0% in the D2M group, and 57.7% in the D2 group. The ND control group had a significantly higher survival rate of 65.9% (P < 0.0001). In the multivariate analyses, both diabetes types were significantly associated with further tooth loss after periodontal treatment.ConclusionsThe diagnosis of diabetes type 1 or 2 seems to be associated with a higher risk of tooth loss after periodontal treatment.Clinical relevanceThe long-term prognosis of teeth in diabetes patients should be judged carefully.